Qt and Emergo speed up medical device approvals
Finnish software company Qt has partnered with global medical device regulatory consulting firm Emergo to accelerate the time-to-market of medical devices manufactured by Qt’s clients.
The partnership will draw upon Qt’s efficient software development framework and Emergo’s expertise in global medical device regulations to help Qt’s customers gain regulatory approvals and enter new markets faster and more cost efficiently.
The medical device industry is heavily regulated in order to ensure the safety and effectiveness of new products, which means bringing them to market is both time and resource consuming, and the average time-to-market falls between three and seven years.
“While Qt, through its software development framework, enables companies to speed up the process of device development, getting past the regulatory hurdles in countries worldwide is still a challenge and can delay the entry to a specific market,” says Dr. Benjamin Grosse-Siestrup, business development manager for Emergo. “By partnering with Emergo, Qt is providing a more complete service offering to its customers along the entire product lifecycle, which includes international medical device and IVD market clearances.”